Federal Register / Vol. 77, No. 31 / Wednesday, February 15, 2012 / Notices 8877 

ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued 

Respondent Citation Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

respondent 

(in hours) 

Total burden 

Importer ............................................. 71.51(b)(3) Dogs/cats: Record of 

sickness or deaths.

20 1 15/60 5 

Importer ............................................. 71.52(d) Turtle Importation Permits 5 1 30/60 3 

Non-Human Primate Importer ........... 71.53(d) Importer Registration— 

Nonhuman Primates.

40 1 10/60 7 

Non-Human Primate Importer ........... 71.53(e) Recordkeeping ................... 30 4 30/60 60 

Importers ........................................... 71.55 Dead bodies ........................... 5 1 1 5 

Importer ............................................. 71.56 (a)(2) African Rodents—Request for exemption.20 1 1 20 

Importer ............................................. 71.56(a)(iii) Appeal ........................... 2 1 1 2 

Total ........................................... ........................................................... 2,740,638 ........................ ........................ 227,330 

Kimberly S. Lane, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2012–2951 Filed 2–14–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

World Trade Center Health Program 

Scientific/Technical Advisory 

Committee (WTCHP STAC or Advisory 

Committee), National Institute for 

Occupational Safety and Health 

(NIOSH) 

Correction 

This notice was published in the 

Federal Register on January 31, 2012, 

Volume 77, Number 20, pages 4820– 

4821. The meeting times and public 

comment times should read as follows: 

Committee Public Meeting Times and 

Dates: (All times are Eastern Standard 

Time). 

12 p.m.–5 p.m., February 15, 2012, and 

8:30 a.m.–4:00 p.m., February 16, 2012. 

Public Comment Times and Dates: 

(All times are Eastern Standard Time.) 

3:45 p.m.–4:45 p.m., on February 15, 

2012, and 

8:45 a.m.–10:45 a.m., on February 16, 

2012. 

Contact Person for More Information: 

Paul J. Middendorf, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 4676 

Columbia Parkway, Mail Stop R–45, 

Cincinnati, Ohio 45226, Telephone: 1 

(888) 982–4748; email: wtcstac@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

Notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 8, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–3487 Filed 2–14–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis (ACET) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 

8:30 a.m.–5:30 p.m., March 6, 2012. 

8:30 a.m.–2:30 p.m., March 7, 2012. 

Place: CDC, Corporate Square, Building 8, 

1st Floor Conference Room, Atlanta, Georgia 

30333, telephone: (404) 639–8317. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 100 people. 

Purpose: This council advises and makes 

recommendations to the Secretary of Health 

and Human Services, the Assistant Secretary 

for Health, and the Director, CDC, regarding 

the elimination of tuberculosis. Specifically, 

the Council makes recommendations 

regarding policies, strategies, objectives, and 

priorities; addresses the development and 

application of new technologies; and reviews 

the extent to which progress has been made 

toward eliminating tuberculosis. 

Matters to be Discussed: Agenda items 

include the following topics: (1) Tuberculosis 

issues in special populations; (2) United 

States-Mexico border activities update; (3) 

tuberculosis outbreaks in federal prisons 

update; (4) ACET Workgroups Activities 

Updates; and (5) other tuberculosis-related 

issues. Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Margie Scott-Cseh, Centers for Disease 

Control and Prevention, 1600 Clifton Road 

NE., M/S E–07, Atlanta, Georgia 30333, 

telephone: (404) 639–8317. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 8, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–3486 Filed 2–14–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

ICD–9–CM Coordination and 

Maintenance (C&M) Committee 

Meeting 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards Staff, announces 

the following meeting. 

Name: ICD–9–CM Coordination and 

Maintenance (C&M) Committee meeting. 

Time and Date: 9 a.m.–5:30 p.m., 

March 5, 2012. 

Place: Centers for Medicare and 

Medicaid Services (CMS) Auditorium, 

7500 Security Boulevard, Baltimore, 

Maryland 21244. 

Status: Open to the public, limited 

only by the space available. The meeting 


sroberts on DSK5SPTVN1PROD with NOTICES
8878 Federal Register / Vol. 77, No. 31 / Wednesday, February 15, 2012 / Notices 

room accommodates approximately 240 

people. 

Security Considerations: Due to 

increased security requirements CMS 

has instituted stringent procedures for 

entrance into the building by nongovernment employees. Attendees will 

need to present valid government-issued 

picture identification, and sign-in at the 

security desk upon entering the 

building. Attendees who wish to attend 

the ICD–9–CM C&M meeting on March 

5, 2012, must submit their name and 

organization by February 27, 2012, for 

inclusion on the visitor list. This visitor 

list will be maintained at the front desk 

of the CMS building and used by the 

guards to admit visitors to the meeting. 

Participants who attended previous 

ICD–9–CM C&M meetings will no longer 

be automatically added to the visitor 

list. You must request inclusion of your 

name prior to each meeting you attend. 

Please register to attend the meeting 

on-line at: http://www.cms.hhs.gov/

apps/events/. 

Please contact Mady Hue (410–786– 

4510 or Marilu.hue@cms.hhs.gov), for 

questions about the registration process. 

Purpose: The ICD–9–CM Coordination 

and Maintenance Committee is a public 

forum for the presentation of proposed 

modifications to the International 

Classification of Diseases, NinthRevision, Clinical Modification. 

Matters to be Discussed: Tentative 

agenda items include: 

March 5, 2012 

ICD–9–CM Procedure Topics: 

Administration of Fidaxomicin 

Placement of Modeling Catheter in 

Endovascular Graft Procedure 

Injection or Infusion of Glucarpidase 

ICD–10 Updates: 

ICD–10 MS–DRG Update 

ICD–10 HAC Translation List 

Impact of ICD–10 MS–DRGs 

Implementation 

ICD–10–CM Diagnosis Topics: 

Atypical femoral fracture 

Choking ‘‘game’’ 

Cognitive sequelae of cerebrovascular 

disease 

Family history of SIDS 

Addenda 

Agenda items are subject to change as 

priorities dictate. 

Note: CMS and NCHS will no longer 

provide paper copies of handouts for the 

meeting. Electronic copies of all meeting 

materials will be posted on the CMS and 

NCHS Web sites prior to the meeting at 

http://www.cms.hhs.gov/

ICD9ProviderDiagnosticCodes/03_

meetings.asp#TopOfPage and http:// 

www.cdc.gov/nchs/icd/icd9cm_

maintenance.htm. 

Contact Persons for Additional 

Information: Donna Pickett, Medical 

Systems Administrator, Classifications 

and Public Health Data Standards Staff, 

NCHS, 3311 Toledo Road, Room 2337, 

Hyattsville, Maryland 20782, email 

dfp4@cdc.gov, telephone 301–458–4434 

(diagnosis); Mady Hue, Health 

Insurance Specialist, Division of Acute 

Care, CMS, 7500 Security Boulevard, 

Baltimore, Maryland 21244, email 

marilu.hue@cms.hhs.gov, telephone 

410–786–4510 (procedures). 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 8, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–3484 Filed 2–14–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices (ACIP) 

Correction 

This notice was published in the 

Federal Register on February 1, 2012, 

Volume 77, Number 21, Page 5026. The 

matters to be discussed and times 

should read as follows: 

Matters To Be Discussed: The agenda 

will include discussions on: 

meningococcal vaccine, hepatitis B 

vaccine, tetanus, diphtheria, and 

acellular pertussis (Tdap) vaccine, 

influenza, vaccine supply, 13-valent 

pneumococcal conjugate vaccine, and 

measles-mumps-rubella (MMR) vaccine. 

Recommendation vote is scheduled for 

Tdap vaccine. Time will be available for 

public comment. 

Agenda items are subject to change as 

priorities dictate. 

Times and Dates: 

8 a.m.–5 p.m., February 22, 2012. 

8 a.m.–12:30 p.m., February 23, 2012. 

The Meeting is Web cast live via the 

World Wide Web; for instructions and 

more information on ACIP please visit 

the ACIP Web site: http://www.cdc.gov/ 

vaccines/recs/acip/. 

Contact Person for More Information: 

Stephanie B. Thomas, National Center 

for Immunization and Respiratory 

Diseases, CDC, 1600 Clifton Road NE., 

MS–A27, Atlanta, Georgia 30333, 

telephone: (404)639–8836; Email 

ACIP@CDC.GOV. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 8, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–3481 Filed 2–14–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Tracking of Participants in the 

Head Start Impact Study. 

OMB No.: 0970–0229. 

Description: The Administration for 

Children and Families (ACF) within the 

Department of Health and Human 

Services (HHS) will collect follow-up 

information from children and families 

in the Head Start Impact Study. In 

anticipation of conducting a future 

follow-up for the study, ACF will collect 

information necessary to identify 

respondents’ current location and 

follow-up with respondents in the 

future. 

The Head Start Impact Study is a 

longitudinal study involving 4,667 first 

time enrolled three- and four-year-old 

preschool children across 84 nationally 

representative grantee/delegate 

agencies. Participants have been 

randomly assigned to either a Head Start 

group or a control group. Data collection 

for the study began in fall of 2002 and 

has been extended through late spring 

2008 to include the participants’ 3rd 

grade year. Tracking of the participants 

has continued every spring beginning in 

2009 and ending in 2011. 

ACF will continue to examine 

outcomes for the sample through the 

spring of the participant’s 12th grade 

year. To maintain adequate sample size, 

telephone interviews will be conducted 

in order to update the respondent’s 

location and contact information. This 

information will be collected from 


sroberts on DSK5SPTVN1PROD with NOTICES